More Amplia Therapeutics Ltd. news
Amplia Therapeutics Ltd.ASX: ATX

S&P DJ Indices Announces March Quarterly Rebalance

Mar 8, 2018 at 9:49 PM EST · Issued by Amplia Therapeutics Ltd.

Filed with ASX · Mar 8, 2018 at 9:49 PM EST · 8 pages · English

On 6ix: 6ix.com/news/sandp-dj-indices-announces-march-quarterly-rebalance-112

Amplia Therapeutics Ltd. on 6ix

Earlier from Amplia Therapeutics

  • Appendix 4C - December 2017 QuarterJan 30, 2018
  • Half Yearly Report and Accounts - HY ending 30 Sep 2017Nov 30, 2017
  • Appendix 4C - September 2017 Quarter CashflowsOct 29, 2017
  • Corporate UpdateOct 19, 2017
  • App 4C - Quarterly Statement of Cashflows - June 2017 QtrJul 27, 2017

Later from Amplia Therapeutics

  • Focus on Immuno-Oncology & Acquisition of 2 Drug CandidatesMar 22, 2018
  • App 4C - March 2018 Quarterly Cash Flow ReportApr 30, 2018
  • Preliminary Final Report - Year Ended 31 March 2018May 30, 2018
  • European Patent Granted for Innates Drug Candidate AMP-886Jul 22, 2018
  • Appendix 4C - June 2018 Quarter Cashflow StatementJul 30, 2018
All Amplia Therapeutics news releases↗

Follow Amplia Therapeutics into a list and get an email when it puts out news.

Follow Amplia Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer